Abstract
Purpose: Survivors of pediatric embryonal brain tumors (BT) are at high risk for sensorineural hearing loss (SNHL) associated with neurocognitive decline. However, previous studies have not assessed the relationship between SNHL and adaptive functioning. We examined neurocognitive and adaptive functioning in patients with and without SNHL. Methods: Participants included 36 patients treated for an embryonal BT with craniospinal irradiation (CSI) and cisplatin chemotherapy who were assessed 6.7 years post-treatment on average. The impact of SNHL on neurocognitive performance and parent-rated adaptive functioning was assessed in univariate and multivariate analyses. Results: There were 17 cases with SNHL (mean age at evaluation = 14.4) and 19 cases with NH (mean age at evaluation = 13.8). After accounting for age at diagnosis and additional covariates in multivariable analyses, SNHL was associated with worse overall intellectual functioning (p = 0.027) and perceptual reasoning (p = 0.016) performance. There was no effect of SNHL on adaptive functioning in multivariable models. Age at diagnosis and sex were associated with performance on neurocognitive measures. Conclusions: SNHL in pediatric embryonal BT is associated with increased risk for neurocognitive deficits in conjunction with other demographic and treatment-related factors.
Original language | English (US) |
---|---|
Pages (from-to) | 147-156 |
Number of pages | 10 |
Journal | Journal of Neuro-Oncology |
Volume | 146 |
Issue number | 1 |
DOIs | |
State | Published - Jan 1 2020 |
Keywords
- Adaptive
- Cognitive
- Embryonal brain tumor
- Medulloblastoma
- Pediatric
- Sensorineural hearing loss
ASJC Scopus subject areas
- Oncology
- Neurology
- Clinical Neurology
- Cancer Research